Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment
by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Updated on: January 07,2024
7
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment
by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Updated on:January 07,2024
7
